StockData
Boundless Bio, Inc. logo

Boundless Bio, Inc. (BOLD) stock

BOLDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$2.40−0.01 (-0.41%)

Close on Nov 18, 2026Market cap $54.60MP/E –Yield –

Boundless Bio revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Boundless Bio

Boundless Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Boundless Bio figures

See a number that looks wrong?